GSK2140944
Showing 1 - 15 of 15
Infections, Bacterial Trial in Las Vegas (Gepotidacin, Cimetidine, Rifampicin)
Completed
- Infections, Bacterial
- Gepotidacin
- +5 more
-
Las Vegas, NevadaGSK Investigational Site
Dec 9, 2021
Infections, Bacterial Trial in La Mesa (Gepotidacin)
Completed
- Infections, Bacterial
-
La Mesa, CaliforniaGSK Investigational Site
Jun 12, 2020
Infections, Bacterial Trial in Anaheim, Austin (Gepotidacin RC Tablet, Gepotidacin HSWG Tablet, Gepotidacin Capsule)
Completed
- Infections, Bacterial
- Gepotidacin RC Tablet
- +2 more
-
Anaheim, California
- +1 more
Sep 14, 2020
Infections, Bacterial Trial in United States (GSK2140944 Lyophile, GSK2140944 Capsules)
Completed
- Infections, Bacterial
- GSK2140944 Lyophile
- GSK2140944 Capsules
-
Phoenix, Arizona
- +29 more
Oct 16, 2017
Infections, Respiratory Tract Trial in Austin (GSK2140944, GSK2140944 , Moxifloxacin)
Completed
- Infections, Respiratory Tract
- GSK2140944
- +3 more
-
Austin, TexasGSK Investigational Site
Jul 10, 2017
Infections, Bacterial Trial in Overland Park (GSK2140944 capsule, GSK2140944 tablet, Itraconazole capsule)
Completed
- Infections, Bacterial
- GSK2140944 capsule
- +2 more
-
Overland Park, KansasGSK Investigational Site
Jul 10, 2017
Infections, Respiratory Tract Trial in London (GSK2140944 for Injection, GSK2140944 Capsule)
Completed
- Infections, Respiratory Tract
- GSK2140944 for Injection
- GSK2140944 Capsule
-
London, United KingdomGSK Investigational Site
Jul 10, 2017
Infections, Respiratory Tract Trial in Minneapolis (GSK2140944, Placebo)
Completed
- Infections, Respiratory Tract
- GSK2140944
- Placebo
-
Minneapolis, MinnesotaGSK Investigational Site
Jun 9, 2017
Infections, Bacterial Trial in Baltimore (GSK2140944 (Single dose), GSK2140944 (Multiple dose))
Completed
- Infections, Bacterial
- GSK2140944 (Single dose)
- GSK2140944 (Multiple dose)
-
Baltimore, MarylandGSK Investigational Site
May 12, 2017
Infections, Respiratory Tract Trial in Overland Park (GSK2140944, Placebo)
Completed
- Infections, Respiratory Tract
- GSK2140944
- Placebo
-
Overland Park, KansasGSK Investigational Site
May 5, 2017
Infections, Respiratory Tract Trial in Randwick (Part A: GSK2140944 Drug single dose of 200mg, 600mg, 1200mg, 1800 mg, and dose
Completed
- Infections, Respiratory Tract
- Part A: GSK2140944 Drug single dose of 200mg, 600mg, 1200mg, 1800 mg, and dose to be determined
- Part B: GSK2140944 Repeat Drug dose of 400mg, 750mg, 1000 mg, and dose to be determined
-
Randwick, New South Wales, AustraliaGSK Investigational Site
May 5, 2017
Infections, Bacterial Trial in Las Vegas (Gepotidacin, Placebo)
Completed
- Infections, Bacterial
- Gepotidacin
- Placebo
-
Las Vegas, NevadaGSK Investigational Site
Aug 18, 2020